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is often present as these areas drain via similar lym-
phatic pathways. Problems associated with lymph-
oedema include altered sensations such as discomfort and
heaviness (Woods 1993), psychological distress (Tobin
et al. 1993), difficulties with physical mobility (Sitzia &
Sobrido 1997) and an increased risk of recurrent infec-
tion (Mortimer 1995).
The intensive lymphoedema management programme,
often referred to as combined decongestive therapy (CDT),
aims to reduce limb volume, restore limb shape and
improve skin and tissue condition (Ko et al. 1998). Daily
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A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-
related lymphoedema
This paper describes a randomized controlled crossover study examining the effects of manual lymphatic
drainage (MLD) in 31 women with breast cancer-related lymphoedema. MLD is a type of massage used in
combination with skin care, support/compression therapy and exercise in the management of lymphoedema.
A modified version of MLD, referred to as simple lymphatic drainage (SLD), is commonly taught as a self-
help measure. There has been limited research into the efficacy of MLD and SLD. The study reported here
explores the effects of MLD and SLD on a range of outcome measures. The findings demonstrate that MLD
significantly reduces excess limb volume (difference, d = 71, 95% CI = 16–126, P = 0.013) and reduced dermal
thickness in the upper arm (d = 0.15, 95% CI = 0.12–0.29, P = 0.03). Quality of life, in terms of emotional
function (d = 7.2, 95% CI = 2.3–12.1, P = 0.006), dyspnoea (d = -4.6, 95% CI = -9.1 to -0.15, P = 0.04) and
sleep disturbance (d = -9.2, 95% CI = -17.4 to -1.0, P = 0.03), and a number of altered sensations, such as pain
and heaviness, were also significantly improved by MLD. The study provides evidence to support the use of
MLD in women with breast cancer-related lymphoedema. The limitations of the study are outlined and future
areas for study are highlighted.
Keywords: manual lymphatic drainage (MLD), breast cancer-related lymphoedema, lymphoedema 
management, lymphoedema therapy, combined decongestive therapy (CDT), massage.
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INTRODUCTION
Secondary lymphoedema develops in one in four women
treated for breast cancer (Kissin et al. 1986; Mortimer
et al. 1996), usually as a result of surgery, radiotherapy or
advanced disease. Swelling commonly affects the arm,
although oedema of the adjacent trunk area and breast 
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treatment is commonly provided over a 3- to 4-week
period using manual lymphatic drainage (MLD), multi-
layer bandaging, isotonic exercises, skin care and, for
some, pneumatic compression pumps. This is followed by
a maintenance phase of self-treatment when the person
wears elastic hosiery and undertakes regular self-massage,
skin care and exercise. Maintenance treatment alone is
indicated for those presenting with mild, uncomplicated
lymphoedema.
MLD was developed in the 1930s by Emil Vodder
(Kasseroller 1998). The therapist uses specific hand move-
ments to provide a gentle pumping action on the skin.
Although this is a type of massage, no oils are used. This
ensures that the maximum skin stretching effect is 
gained with the minimum of pressure. As a result, lymph
flow improves without increasing capillary filtration 
(Wittlinger & Wittlinger 1992).
MLD has been shown to have a number of physiologi-
cal effects. These include an increase in the contraction
rate of lymphatics (Hutzschenreuter et al. 1989), increased
reabsorption of protein into lymphatics (Leduc et al.
1988), reduced microlymphatic hypertension (Franzeck
et al. 1997) and improved collateral lymph drainage
between the lymphatic territories of the skin (Ferrandez
et al. 1996). Improved drainage enables fluid to be redi-
rected away from oedematous areas towards the func-
tioning lymph nodes in unaffected areas, an important
principle in lymphoedema management. Wittlinger &
Wittlinger (1992) also suggest that MLD influences the
sympathetic nervous system, promoting relaxation. A
simplified version of MLD, often referred to as simple
lymphatic drainage (SLD), is commonly taught in the UK
to people with lymphoedema, and to their relatives, as a
self-help measure (British Lymphology Society 1999).
To date, the evidence-base for MLD and SLD is limited.
Most studies of lymphoedema management have focused
on the combined effects of CDT (Mirolo et al. 1995; Sitzia
& Sobrido 1997; Ko et al. 1998). Others have evaluated
specific interventions such as multilayer bandaging and
hosiery (Badger et al. 2000) or manual lymphatic drainage
and compression (Zanolla et al. 1984; Johansson et al.
1998; Johansson et al. 1999; Andersen et al. 2000).
Zanolla et al. (1984) studied women with breast cancer-
related lymphoedema, comparing patients receiving MLD
with those having treatment with pneumatic compression
pumps. Limb circumference and subjective assessment of
mood were used to measure change. The findings showed
similar results for MLD and compression pumps, although
the authors concluded that the research was limited
owing to small numbers and lack of standardization of
method. Johansson et al. (1998) also compared MLD with
pneumatic compression pumps and found no significant
difference between the two treatments. A further study
(Johansson et al. 1999) measured the effects of compres-
sion bandaging with or without MLD in arm swelling.
The group receiving bandaging and MLD had 
a significant reduction in limb volume (P = 0.04) and
decreased pain (P = 0.03), despite the fact that MLD was
only given for 1 week. A recent study (Andersen et al.
2000) investigated the effect of eight sessions of MLD over
2 weeks, in addition to the standard programme of com-
pression garments, skin care, exercises and information,
in 42 women with breast cancer-related lymphoedema.
The findings suggested that MLD did not contribute 
significantly to oedema reduction (Andersen et al. 2000),
although the MLD treatment course was relatively short
and the study group was limited to those with mild to
moderate swelling (limb volume <30%).
STUDY AIMS
The aims of the study reported in this paper were:
1 to measure the effects of MLD and SLD on lymph-
oedema of the arm and trunk;
2 to measure the effects of MLD and SLD on quality of
life and symptoms/altered sensations associated with
lymphoedema.
PATIENTS AND METHODS
Research design
The study used a randomized, controlled crossover design
with two study groups: patients who received MLD fol-
lowed by SLD and patients who received SLD followed by
MLD. For the purposes of the study, SLD was used as a
comparative intervention, as it was not believed possible
to provide placebo or ‘sham’ MLD.
Sample
Participants were drawn from the lymphoedema clinic at
a large cancer hospital. Subjects who fulfilled the follow-
ing criteria were eligible for the study: unilateral breast
cancer-related lymphoedema for more than 3 months, 
two consistent limb volume measurements of >10%
excess volume, >1 year post cancer treatment, clinically
detectable trunk swelling and the ability to provide
written consent. Those with active cancer and those on
diuretic therapy or other oedema-influencing drugs were
excluded from the study. Approval was obtained from the
hospital ethics committee and all participants provided
written informed consent. In total, 31 subjects were
recruited to the study, with 15 randomized to group A 
and 16 randomized to group B for the 12 week study
period.
Treatment interventions
Group A received 3 weeks of daily MLD followed by a 6-
week non-treatment period. This was followed by 3 weeks
of daily SLD. Group B received 3 weeks of SLD, followed
by a 6-week non-treatment period and then 3 weeks of
MLD (Fig. 1).
Three therapists fully qualified in the Vodder method of
MLD provided the MLD treatments, which were stand-
ardized, with each therapist following the same protocol
for treatment to the neck, anterior and posterior trunk and
swollen arm, always moving fluid towards the unaffected
side. The details of each treatment session were recorded
daily on a diary sheet. Treatment consisted of a 45-min
MLD session, performed Monday to Friday, over a 3-week
period (a total of 15 treatments).
The SLD was taught by the researcher and therapists
and performed by subjects for 20min each day during the
SLD period. Subjects were given a leaflet describing the
SLD sequence, which comprised treatment to the neck,
unaffected axilla and anterior chest wall, followed by
abdominal breathing exercises. Specific movements were
taught for the neck and axilla and subjects were instructed
to use a relaxed hand to gently stretch the skin on the
chest wall in the direction away from the swollen area,
repeating the movements five times in various positions.
Their technique was monitored weekly during the study
and each participant kept a diary recording the areas
covered and time taken each day for SLD.
All subjects were given advice on skin care and infor-
mation on lymphoedema and were fitted with new elastic
sleeves at the beginning of the MLD and SLD treatment
periods.
Assessments and outcome measures
Baseline and demographic data were recorded for each
subject and included age, limb volume, time since breast
cancer treatment, duration of lymphoedema, side of
swelling and details of breast cancer treatment. The prin-
cipal researcher (A.F.W.) undertook all the measurements
and did not provide any of the MLD treatments. The 
following measurements were recorded before and after
MLD and SLD at weeks 0, 3, 9 and 12.
Excess limb volume
Limb volume was determined by using the formula for
calculating the volume of a cylinder (v = c2/P) (Kuhnke
1976). Circumferential measurements were taken with a
tape measure at 4-cm intervals along the arm, allowing
calculation of the total volume of affected and unaffected
arm. Excess limb volume represented the difference
between both limbs, expressed in millilitres.
Caliper creep on the affected and unaffected sides 
as measured by modified Harpenden skinfold 
calipers and the line method
Individuals with arm lymphoedema secondary to breast
cancer treatment commonly have trunk swelling in the
area behind the axilla. Modified skinfold calipers have
been shown to be an indicator of trunk oedema, as mea-
sured by the change in skinfold size (caliper creep), pro-
vided the method is standardized (Roberts et al. 1995). In
lymphoedema, the displacement of interstitial fluid 
as a result of the caliper pressure is influenced by the
degree of oedema. The creep value is therefore greater
when the level of trunk oedema is high, as more fluid is
displaced.
The skinfold calipers are applied to each end of a hori-
zontal 4-cm line drawn on a predetermined, anatomical
point on the trunk at the posterior axillary area, and held
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Figure 1. Outline of interventions.
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in place for 60s. The skinfold sizes at 10s and 60s are
recorded and caliper creep is calculated as the difference
between these two readings.
Dermal thickness on the affected side using 
high-resolution, high-frequency skin 
ultrasound
Lymphoedema affects the skin and underlying tissues, and
previous research has suggested that ultrasound may
provide information on the amount of oedema present in
these areas (Gniadecka 1996). The thickness of the dermis
is likely to be influenced by the level of oedema present,
although the validity and reliability of skin ultrasound in
the identification and measurement of dermal thickness
has not been fully ascertained. Easy accessibility to the
method prompted its use in this study, particularly as a
step towards developing new outcomes measures in a 
currently limited field.
A 20-MHz ultrasound scanner (Hadsund, Dermascan-C,
Cortex Technology APS, Denmark) was used to obtain
cross-sectional images of the skin at four sites on the
swollen arm: (a) 8cm down from the elbow crease on the
inner forearm (forearm); (b) 12cm down from the supra-
clavicular joint over the deltoid muscle (deltoid); (c) 4cm
out from the posterior axillary crease on the back (poste-
rior axilla); (d) 12cm down from the axillary crease on the
side above the waist (flank). Sites were always located to
anatomical reference points to ensure the same site was
used for subsequent readings. A ring of hydrocolloid dress-
ing (Granuflex®) was cut to the size of the scanner head
and placed on the skin over each measurement site. This
ensured that the image size and distance from the skin
was always the same and allowed a standard amount 
of ultrasound gel to be used within the Granuflex® ring.
Dermal thickness was calculated in millimetres by mea-
suring the distance on each image between the surface
entry/echo line and the border between the lower dermis
and subcutaneous layer using specifically designed pro-
grammes on Matlab® software.
EORTC QLQ C30 quality of life questionnaire
At the time of the study, there were no condition-specific
quality of life tools available for lymphoedema. This
patient-completed instrument consists of 30 functional,
symptom and individual items designed to address a range
of quality of life issues relevant to a broad spectrum of
cancer patients (Aaronson et al. 1993). Permission to use
the instrument was obtained.
Symptoms/altered sensations scales
Researchers such as Woods (1993) and Casley-Smith et al.
(1993) have highlighted the effect of lymphoedema treat-
ment on various symptoms and sensations associated
with lymphoedema, although there are no instruments
currently validated to measure these changes. For the pur-
poses of this study, six women with arm swelling were
questioned regarding the altered sensations experienced
by people with breast cancer-related lymphoedema. A 12-
item patient self-report questionnaire was developed and
was tested for content validity, prior to the study, through
discussions with another four patients and two lymph-
oedema specialists. The final questionnaire consisted 
of 11 sensations of pain, discomfort, heaviness, full-
ness, bursting, hardness, heat, cold, numbness, weak-
ness and tingling to which rating scales of 0–5 were
applied (0 = none and 5 = worst possible), and one 
overall distress scale. Subjects recorded the scores for
before and after treatment on the same questionnaire in
different colours to enable them to make a subjective
comparison.
Statistical analysis
The mean difference between pre- and post-treatment
values was recorded for both MLD and SLD treatment
periods in all outcome measures, except for the symp-
toms/altered sensations scales. Comparison was made
using paired t-tests. Results were expressed as mean dif-
ferences, with 95% confidence intervals (CIs) produced 
for the differences. Significant interaction was assumed 
to have occurred should the difference between statis-
tical groups achieve P < 0.05. In the symptoms/altered
sensations measures, analysis was based on the pro-
portion in whom the symptom improved over the treat-
ment period, analysed by matched pairs for the different
treatments.
RESULTS
There were no statistically significant differences in base-
line clinical and demographic data between groups A and
B (Table 1). Two subjects withdrew because of ill-health
(one developed herpes zoster infection and the other devel-
oped a chest infection). Both were randomized to group B
and had completed the SLD period of the study. A total of
29 subjects completed both the MLD and SLD treatment
periods.
Excess limb volume
MLD produced a statistically significant reduction in
excess limb volume (mean difference, d = 71ml, 95%
CI = 16–126, P = 0.013) (Table 2). Following SLD, there
was a non-significant mean reduction in excess limb
volume of 30ml (d = 30ml, 95% CI = -4 to 63, P = 0.08).
The difference between excess limb volume post-MLD
and post-SLD just failed to achieve statistical significance
(d = 39ml, 95% CI = -1 to 78, P = 0.053) (Table 3).
Caliper creep
Caliper readings were available from 21 subjects and
showed that MLD reduced caliper creep on the affected
side (d = 0.23mm, 95% CI = -0.01 to 0.47, P = 0.06)
(Table 4), indicating an almost significant reduction in
trunk oedema. Following SLD there was non-significant
increase in caliper creep on the affected side. Comparison
of post-MLD and post-SLD creep values did not achieve
statistical significance (Table 5).
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Table 1. Comparison of details of patients in groups A (MLD first) and B (SLD first)
Group A Mean (SEM) Group B Mean (SEM) P-value
Number 15 16
Age 59.7 (2.1) 59.3 (2.4) 0.897
Limb volume (% excess) 30.1 (4.9) 39.5 (4.4) 0.167
Time since cancer diagnosed (months) 125.9 (21.8) 145.1 (22.1) 0.543
Duration of lymphoedema (months) 82.5 (14.7) 118.4 (22.0) 0.191
Side of swelling
Right 5 (33%) 7 (44%) 0.552
Left 10 (67%) 9 (56%)
Breast cancer treatment
Local excision 9 (60%) 8 (50%) 0.576
Mastectomy 6 (40%) 8 (50%)
Axillary sampling 8 (53%) 12 (75%) 0.338
Axillary clearance 6 (40%) 4 (25%)
No surgery 1 (7%) 0 (-)
Breast radiotherapy
Yes 12 (80%) 14 (88%) 0.57
No 3 (20%) 2 (12%)
Axillary radiotherapy 
Yes 10 (67%) 11 (69%) 0.901
No 5 (33%) 5 (31%)
Tamoxifen
Yes 7 (47%) 3 (19%) 0.097
No 8 (53%) 13 (81%)
Table 2. Mean change in excess volume (ml) before and after MLD and SLD 
Number of Mean excess volume Mean excess volume Mean change 95% CI t P-value
patients before treatment after treatment
MLD 29 746 674 71 (16–126) 2.66 0.013
SLD 31 753 724 30 (-4 to 63) 1.81 0.08
Table 3. Comparison of mean difference in excess limb volume (ml)after MLD and SLD 
Number of patients Mean excess Mean excess Mean difference 95% CI t P-value
volume after MLD volume after SLD
29 674 713 39 (-1 to 78) 2.02 0.053
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Dermal thickness
MLD significantly reduced dermal thickness at the
deltoid site on the upper arm (d = 0.15, 95%
CI = 0.12–0.29, P = 0.03) while SLD did not (Table 6).
Neither MLD nor SLD demonstrated significant changes
at the forearm, posterior axilla or flank sites.
Quality of life
Results from the EORTC QLQ C30 self-report question-
naire showed that MLD improved emotional function in
terms of reducing worry, irritability, tension and feelings
of depression (d = 7.2, 95% CI = 2.3 to 12.1, P = 0.006). It
also improved dyspnoea (d = -4.6, 95% CI = -9.1 to -0.15,
P = 0.04) and reduced sleep disturbance (d = -9.2, 95%
CI = -17.4 to -1.0, P = 0.03). The other subscales did not
achieve statistical significance with MLD. SLD did not
result in significant changes to any of the quality of life
parameters.
Symptoms/altered sensations
This self-report questionnaire showed that MLD was 
significantly more likely than SLD to improve pain 
[odds ratios (OR) = 9.0, 95% CI = 1.2–394.5, P = 0.01), 
discomfort (OR = 12.0, 95% CI = 1.8–513.0, P = 0.002),
heaviness (OR = 11.0, 95% CI 1.6–473.5, P = 0.003), 
fullness (P < 0.001), bursting (P = 0.008) and hardness
(OR = 18.0, 95% CI = 2.8 to 750.0, P < 0.001).
DISCUSSION
A physical treatment programme combining MLD,
support and compression with multilayer bandaging
and/or hosiery, skin care and exercise is recognized as best
practice in lymphoedema management (Ko et al. 1998).
Petrek et al. (1998) recently highlighted the need to
provide evidence for the efficacy of each specific therapy
within this programme. The randomised-controlled trial
reported here aimed to measure objectively the extent to
Table 4. Mean difference in caliper creep (mm) before and after MLD and SLD on affected and unaffected side
Number of Mean creep Mean creep Mean 95% CI t P-value
patients before treatment after treatment difference
MLD
Affected side 21 1.18 0.95 0.23 (-0.01 to 0.47) 1.99 0.06
Unaffected side 21 0.78 1.06 -0.28 (-0.56 to 0.00) 2.06 0.053
SLD
Affected side 23 0.97 1.04 -0.07 (-0.22 to 0.09) 0.90 0.38
Unaffected side 23 1.03 0.96 0.07 (-0.18 to 0.32) 0.58 0.57
Table 6. Mean difference in dermal depth (mm) before and after MLD and SLD on affected side at four sites
Number of Mean depth Mean depth Mean 95% CI t P-value
patients before treatment after treatment difference
Forearm
MLD 28 2.37 2.36 0.01 (-0.10 to 0.12) 0.19 0.85
SLD 31 2.37 2.34 0.03 (-0.09 to 0.15) 0.48 0.63
Deltoid
MLD 26 2.48 2.32 0.15 (0.12 to 0.29) 2.30 0.03
SLD 29 2.46 2.38 0.08 (-0.05 to 0.20) 1.30 0.21
Posterior axilla
MLD 28 2.20 2.08 0.12 (-0.03 to 0.26) 1.66 0.11
SLD 31 2.18 2.22 0.04 (-0.17 to 0.10) 0.56 0.58
Flank
MLD 28 2.02 1.99 0.03 (-0.14 to 0.20) 0.37 0.71
SLD 29 2.10 2.02 0.08 (-0.02 to 0.18) 1.62 0.12
Table 5. Mean difference in caliper creep (mm) on affected side after MLD and SLD 
Number of patients post MLD mean creep post SLD mean creep Mean difference 95% CI t P-value
210 95 1.00 -0.06 (-0.33 to 0.22) 0.43 0.669
which MLD influenced a number of treatment outcomes.
This was a quasi-experimental design in which efforts
were made to control and record treatment variables and
reduce researcher bias. SLD was used as the comparative
intervention as it was not believed possible to provide
‘sham’ MLD.
The results showed that MLD provided a statistically
significant reduction in limb volume and improvement in
several quality of life parameters and symptoms associ-
ated with lymphoedema. These findings support the use
of MLD in the management of breast cancer-related lym-
phoedema, although the study does have a number of lim-
itations.
Although the researcher did not provide the MLD treat-
ments or take part in the randomization process, she was
aware, at each measurement point, of what treatments
had been provided and, thus, may have unintentionally
biased the data. Subjects were also aware of which treat-
ment intervention they were receiving at each point
during the trial. The placebo effect of daily contact with
therapists is difficult to predict, but clearly the experience
of having massage and the relationship between therapist
and subject could influence individual subjects’ percep-
tion of the MLD treatment.
The study used a variety of outcome measures. The
method of measuring and calculating limb volume in this
study has been shown to be reliable, particularly when
used in a consistent manner by the same operator (Stanton
et al. 2000). However, as already noted, many patients also
present with oedema of the trunk, particularly in the area
posterior to the axilla. To date, there has been little explo-
ration of methods for assessing trunk swelling and, 
consequently, it was felt useful to incorporate the use of
the modified Harpenden skinfold calipers and ultrasound
scanner within this study.
The modified skin calipers provide a reproducible and
portable method for assessing trunk oedema (Roberts
et al. 1995), although data were obtainable in only 21
patients. Four subjects were obese, which created diffi-
culties in holding the calipers in place. In two subjects
there were difficulties in lifting the skinfold because of
radiation damage. Another had scarring from reconstruc-
tive surgery and a further subject was unable to tolerate
the caliper pressure because of skin sensitivity due to mul-
tiple infective episodes.
The mean caliper data from the affected, swollen side
almost reached significance and the results may have been
influenced by the small data set. However, the non-sig-
nificant (P = 0.09) but marked increase in caliper creep on
the unswollen side after MLD appears to indicate move-
ment of lymph into this unaffected area, as would be
expected (Table 4). This suggests that the calipers are sen-
sitive to changes in trunk oedema and further validatory
work is required.
Lymphoedema is known to affect the dermal and 
subcutaneous layers of the skin. High-frequency ultra-
sonography provides a non-invasive approach to skin
assessment and has been shown to give information on
intradermal oedema (Gniadecka 1996; Hu et al. 1998). In
the present study, it was assumed that an increase in
water content (oedema) would directly influence dermal
thickness. Certainly, the baseline dermal thickness mea-
surements at all four sites used in this study were greater
on the oedematous side. It is likely, however, that the use
of ultrasound images in the assessment and measurement
of skin and tissue condition in lymphoedema is complex.
Lower frequency ultrasound would provide more infor-
mation on subcutaneous thickness, and further studies
are required to validate the use of ultrasound in the assess-
ment of lymphoedema and measurement of treatment
response.
Simple lymphatic drainage was used in this study as the
comparative intervention. It did not achieve a significant
effect with the outcome measures, although there was a
trend to reduction in limb volume. Clinical experience
shows that SLD is useful over the long term and provides
an effective self-treatment which is particularly indicated
when MLD is not available or in the months following
CDT or MLD (British Lymphology Society 1999). Subjects
in the study appeared to learn SLD more readily once they
had experienced MLD, although some did find SLD diffi-
cult to use, and consideration must be given to how the
technique is taught and monitored over time. The quality
of SLD and length of treatment times may have influenced
results within this study, and future exploration of SLD
should be undertaken within a longitudinal design.
Manual lymphatic drainage provides a means of redi-
recting fluid from lymphoedematous areas towards func-
tioning lymphatics. It is also the treatment of choice 
for trunk, breast, head and neck and genital oedema in
patients in whom the application of support and com-
pression is often impractical. This study has provided
insight into the effects of MLD, without the influence of
multilayer bandaging, and results indicate that manual
lymphatic drainage has a useful role in the management
of breast cancer-related lymphoedema.
The use of a randomized crossover design and a variety
of outcome measures have provided a range of quantita-
tive and qualitative data on the effects of MLD. The limi-
tations of the study are acknowledged. Further studies 
are required to explore the effects of MLD and SLD over
the longer term and in different types of lymphoedema, 
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in order to establish the cost-effectiveness of these
approaches within the lymphoedema treatment pro-
gramme. Work should also be undertaken to further
develop and validate outcome measures in this field.
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